Notification

Divine Hira Jewellers IPO is Open!

Apply for the Divine Hira Jewellers IPO through UPI in just minutes.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Sun Pharma Adv.res.co.ltd Share Price

₹ 130.34 4.32 (3.42%)

Mar 19 2025 03:30 PM Pharmaceuticals NSE: SPARC

Sun Pharma Adv.res.co.ltd Share Price Update

As of the latest trading session, Sun Pharma Adv.res.co.ltd share price is currently at 130.34, which is up by 4.32 from its previous closing. Today, the stock has fluctuated between 125.60 and 133.50. Over the past year, Sun Pharma Adv.res.co.ltd has achieved a return of -65.28 %. In the last month alone, the return has been -3.08 %. Read More...

Sun Pharma Adv.res.co.ltd Performance

Day Range

Low125.60 High133.50

130.34

52 Week Range

Low 109.30 High 472.80

130.34

Sun Pharma Adv.res.co.ltd Share Price

14788

532872

SPARC

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

125.60 Prev. Close

126.01 Volume (Shares)

2481753.00

Total traded value

3234.71

Upper Circuit

151.21 Lower Circuit

100.80

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Sun Pharma Adv.res.co.ltd Fundamentals

(Standalone)

Market Cap (Cr)	4229.81
PE Ratio (TTM)	-10.44
Book Value / Share	3.84
Beta	1.24

ROE	0.00%
EPS (TTM)	0.00
Dividend Yield	0.00%
Net Profit Qtr (Cr)	-79.71

Sun Pharma Adv.res.co.ltd Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	14.91
Operating Expense	94.81
Net Profit	-79.71
Net Profit Margin (%)	-534.60
Earnings Per Share (EPS)	-2.46
EBITDA	-74.19
Effective Tax Rate (%)	0.00

Particulars	SEP 2024 (Values in Cr)
Revenue	12.86
Operating Expense	120.59
Net Profit	-107.69
Net Profit Margin (%)	-837.40
Earnings Per Share (EPS)	-3.32
EBITDA	-103.81
Effective Tax Rate (%)	0.00

Particulars	JUN 2024 (Values in Cr)
Revenue	16.81
Operating Expense	115.21
Net Profit	-96.84
Net Profit Margin (%)	-576.08
Earnings Per Share (EPS)	-2.98
EBITDA	-93.56
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	16.56
Operating Expense	127.64
Net Profit	-106.69
Net Profit Margin (%)	-644.26
Earnings Per Share (EPS)	-3.29
EBITDA	-103.12
Effective Tax Rate (%)	0.00

Particulars	DEC 2023 (Values in Cr)
Revenue	13.86
Operating Expense	119.90
Net Profit	-99.65
Net Profit Margin (%)	-718.97
Earnings Per Share (EPS)	-3.07
EBITDA	-96.23
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	75.55
Operating Expense	493.13
Net Profit	-388.11
Net Profit Margin (%)	-513.71
Earnings Per Share (EPS)	-11.96
EBITDA	-374.32
Effective Tax Rate (%)	0.00

Particulars	MAR 2023 (Values in Cr)
Revenue	238.78
Operating Expense	472.24
Net Profit	-222.58
Net Profit Margin (%)	-93.21
Earnings Per Share (EPS)	-7.82
EBITDA	-203.18
Effective Tax Rate (%)	0.00

Particulars	MAR 2022 (Values in Cr)
Revenue	137.25
Operating Expense	347.49
Net Profit	-203.40
Net Profit Margin (%)	-148.19
Earnings Per Share (EPS)	-7.73
EBITDA	-179.91
Effective Tax Rate (%)	0.00

Particulars	MAR 2021 (Values in Cr)
Revenue	252.96
Operating Expense	409.51
Net Profit	-151.14
Net Profit Margin (%)	-59.74
Earnings Per Share (EPS)	-5.77
EBITDA	-129.57
Effective Tax Rate (%)	0.00

Particulars	MAR 2020 (Values in Cr)
Revenue	76.82
Operating Expense	398.98
Net Profit	-312.40
Net Profit Margin (%)	-406.66
Earnings Per Share (EPS)	-11.92
EBITDA	-300.24
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	3.88
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.12
EBITDA Margin	-493.22

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	15.80
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.03
EBITDA Margin	-85.09

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	3.85
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.11
EBITDA Margin	-495.46

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	15.80
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.17
EBITDA Margin	-85.09

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	-7.47
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	-131.07

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	-6.42
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	-51.22

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	-0.71
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.25
EBITDA Margin	-390.90

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	155.32
Total Assets	515.04
Total Liabilities	515.04
Total Equity	125.75
Share Outstanding	324521588
Price to Book Ratio	96.09
Return on Assets (%)	-75.18
Return on Capital (%)	-224.14

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	111.57
Total Assets	830.12
Total Liabilities	830.12
Total Equity	512.77
Share Outstanding	324521588
Price to Book Ratio	11.36
Return on Assets (%)	-26.81
Return on Capital (%)	-43.4

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	155.06
Total Assets	486.33
Total Liabilities	486.33
Total Equity	124.85
Share Outstanding	324521588
Price to Book Ratio	96.09
Return on Assets (%)	-79.80
Return on Capital (%)	-225.83

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	111.57
Total Assets	830.12
Total Liabilities	830.12
Total Equity	512.77
Share Outstanding	324521588
Price to Book Ratio	11.36
Return on Assets (%)	-26.81
Return on Capital (%)	-43.4

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	1.22
Total Assets	280.08
Total Liabilities	280.08
Total Equity	31.22
Share Outstanding	271878966
Price to Book Ratio	-39.74
Return on Assets (%)	-72.61
Return on Capital (%)	-191.47

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	9.31
Total Assets	229.68
Total Liabilities	229.68
Total Equity	-168.25
Share Outstanding	262047506
Price to Book Ratio	-22.07
Return on Assets (%)	-65.80
Return on Capital (%)	-242.62

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	0.45
Total Assets	272.56
Total Liabilities	272.56
Total Equity	-18.63
Share Outstanding	262047506
Price to Book Ratio	-135.92
Return on Assets (%)	-114.61
Return on Capital (%)	-654.39

Particulars	MAR 2024 (Values in Cr)
Net Income	-386.83
Cash from Operations	-425.07
Cash from Investing	391.52
Cash from Financing	42.40
Net change in Cash	4.74
Free Cash Flow	-398.56

Particulars	MAR 2023 (Values in Cr)
Net Income	-222.58
Cash from Operations	-74.48
Cash from Investing	-548.27
Cash from Financing	616.75
Net change in Cash	-0.64
Free Cash Flow	-59.09

Particulars	MAR 2024 (Values in Cr)
Net Income	-388.10
Cash from Operations	-425.31
Cash from Investing	391.11
Cash from Financing	42.79
Net change in Cash	4.47
Free Cash Flow	-398.80

Particulars	MAR 2023 (Values in Cr)
Net Income	-222.58
Cash from Operations	-74.48
Cash from Investing	-548.27
Cash from Financing	616.75
Net change in Cash	-0.64
Free Cash Flow	-59.09

Particulars	MAR 2022 (Values in Cr)
Net Income	-203.39
Cash from Operations	-212.77
Cash from Investing	-29.16
Cash from Financing	229.32
Net change in Cash	-8.07
Free Cash Flow	-180.09

Particulars	MAR 2021 (Values in Cr)
Net Income	-151.13
Cash from Operations	-150.26
Cash from Investing	1.56
Cash from Financing	159.28
Net change in Cash	8.95
Free Cash Flow	-144.26

Particulars	MAR 2020 (Values in Cr)
Net Income	-312.40
Cash from Operations	-200.94
Cash from Investing	155.34
Cash from Financing	55.46
Net change in Cash	0.00
Free Cash Flow	-146.90

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	35.26	18.96	1.92	270.21	34.11 / 77.70
BLISS GVS PHARMA LTD	117.60	15.41	1.22	1239.15	92.25 / 184.95
CIPLA LTD	1508.70	24.42	4.29	121844.87	1317.60 / 1702.00
FERMENTA BIOTECH LIMITED	245.70	20.36	2.49	723.12	145.00 / 449.00

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L	35.26	21.24	5.99	270.21	34.11 / 77.70
AMRUTAJAN HEALTH LTD	603.65	35.38	5.86	1745.19	548.05 / 861.40
ASTRAZENECA PHARMA IND LT	7928.65	118.25	29.17	19821.63	4050.15 / 8139.85
BLISS GVS PHARMA LTD	117.60	15.27	1.20	1239.15	92.25 / 184.95

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 123.60
26 Days 133.40
10 Days 124.70
50 Days 148.50
12 Days 125.40
100 Days 171.60
20 Days 129.60
200 Days 197.80

123.85
PIVOT

First Resistance	130.01
Second Resistance	134.00
Third Resistance	140.16

First Support	119.86
Second Support	113.70
Third Support	109.71

RSI	43.18
MACD	-7.93
Commodity Channel Index (CCI)	-31.87

ADX	36.90
Williams % R	-49.29

Sun Pharma Adv.res.co.ltd Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

31.46 Promoter Holdings

65.67 FII

2.22 DII

0.63 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Shanghvi Finance Private Limited	Shareholding of Promoter and Promoter Group	1.37211787E8	42.28
Dilip Shantilal Shanghvi	Shareholding of Promoter and Promoter Group	6.181066E7	19.05
Sun Pharmaceutical Industries Key Employees Benefit Trust	Public Shareholding	1.0317377E7	3.18
Lakshdeep Investments & Finance (p) Ltd.	Public Shareholding	6033835.0	1.86
Rekha Jhunjhunwala	Public Shareholding	5164000.0	1.59
Aditya Medisales Limited	Shareholding of Promoter and Promoter Group	4888126.0	1.51
Raksha S.valia	Shareholding of Promoter and Promoter Group	4145231.0	1.28
Vijay Mohanlal Parekh	Public Shareholding	3661304.0	1.13
Paresh Mohanlal Parekh	Public Shareholding	3646837.0	1.12
Enam Securities Private Limited	Public Shareholding	3370786.0	1.04
Sudhir Valia	Shareholding of Promoter and Promoter Group	1833951.0	0.57
Unimed Investments Limited	Shareholding of Promoter and Promoter Group	1267963.0	0.39
Vibha Dilip Shanghvi	Shareholding of Promoter and Promoter Group	1063236.0	0.33
Vidhi Dilip Shanghvi	Shareholding of Promoter and Promoter Group	344081.0	0.11
Aalok Dilip Shanghvi	Shareholding of Promoter and Promoter Group	350162.0	0.11
Shanghvi Family & Friends Benefit Trust (kumud S. Shanghvi And Dilip S. Shanghvi)	Shareholding of Promoter and Promoter Group	154922.0	0.05
Kumud S. Shanghvi	Shareholding of Promoter and Promoter Group	38795.0	0.01
Gujarat Sun Pharmaceutical Industries Pvt Ltd	Shareholding of Promoter and Promoter Group	1751.0	0.0
Sanghvi Properties Private Limited	Shareholding of Promoter and Promoter Group	1887.0	0.0
Flamboyawer Finance Private Limited	Shareholding of Promoter and Promoter Group	2543.0	0.0

Sun Pharma Adv.res.co.ltd

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type

Learn More About Stocks

India proposes 12% safeguard duty on flat steel imports for 200 days

India’s DGTR has proposed a 12% safeguard duty on flat steel imports for 200 days, affecting major steel stocks. JSW Steel share price and Tata Steel share price will be under watch as Nifty Metal Index gains 10% in March 2025.

19 Mar, 2025 | 2 Min. read

Premier Explosives Secures Rs 189 Million Defence Export Order

Premier Explosives secures a Rs 189 million export order for defence explosives, boosting its global presence. Premier Explosives share price likely to be in focus.

19 Mar, 2025 | 2 Min. read

Delhi’s Power Demand to Cross Record 9,000 MW This Summer

Delhi’s power demand is set to exceed 9,000 MW for the first time. Renewable energy sources will support supply. Solar Energy Corporation of India share price in focus.

19 Mar, 2025 | 2 Min. read

G R Infraprojects Secures NHAI Project Worth Rs 42.63 Billion

G R Infraprojects receives a letter of award from NHAI for a project worth Rs 42.63 billion. G R Infraprojects share price likely to remain in focus.

19 Mar, 2025 | 2 Min. read

Moody’s Affirms IndusInd Bank Ratings, Places BCA on Review for Downgrade

Moody’s has affirmed IndusInd Bank’s Ba1 rating with a stable outlook but placed its Baseline Credit Assessment (BCA) on review for downgrade due to risk concerns.

18 Mar, 2025 | 2 Min. read

Manappuram Finance Board to Consider Fundraising Proposals on March 20

Manappuram Finance’s board to meet on March 20 to discuss fundraising through equity shares, warrants, or debt securities. Shares remain in focus amid stake sale reports.

18 Mar, 2025 | 3 Min. read

Tata Motors Incorporates Digital.AI Labs to Expand in IT Sector

Tata Motors has launched Tata Motors Digital.AI Labs Limited, a wholly owned subsidiary focused on IT and digital solutions. Tata Motors share price remains in focus.

18 Mar, 2025 | 3 Min. read

IRCON Wins Rs.285 Crore Order in Meghalaya Secretariat Project

IRCON International secures a Rs.285 crore share in a Rs.1,096.17 crore EPC contract for a new Secretariat Complex in Meghalaya. Project completion is set for 36 months.

18 Mar, 2025 | 3 Min. read

Zydus Life Gets Final USFDA Approval for Eluxadoline Tablets

Zydus Lifesciences Ltd. receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg, securing 180-day shared exclusivity in the US market.

17 Mar, 2025 | 2 Min. read

Galaxy Surfactants Declares ₹18 Per Share Interim Dividend for FY25

Galaxy Surfactants announces an interim dividend of ₹18 per equity share for FY25. The record date is March 20, 2025, with payment to be made within 30 days.

17 Mar, 2025 | 2 Min. read

About Sun Pharma Adv.res.co.ltd

Companies Owned by Sun Pharma Adv.res.co.ltd

We have something for everyone

Explore More Investment Options

Start Investing

Stocks

Secure and enhance your financial future today

Invest

IPOs

Your gateway to future financial opportunities

Invest

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x

Invest

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest

Frequently Asked Questions

What is the Share Price of Sun Pharma Advanced Research Company Ltd?

Answer Field: The share price of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 130.34 and for BSE is ₹ 129.85.

What is the Market Cap of Sun Pharma Advanced Research Company Ltd?

Answer Field: The market cap of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 42,29.81 Cr. and for BSE is ₹ 42,13.91 Cr. as of now.

What is the 52 Week High and Low of Sun Pharma Advanced Research Company Ltd?

Answer Field: The 52 Week High and Low of Sun Pharma Advanced Research Company Ltd for NSE is ₹ 472.80 and ₹ 109.30 and for BSE is ₹ 474.00 and ₹ 109.20.

How to Buy Sun Pharma Advanced Research Company Ltd share?

Answer Field: You can trade in Sun Pharma Advanced Research Company Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sun Pharma Advanced Research Company Ltd?

Answer Field: The 1 year returns on the stock has been -65.28%.

What is the Current Share Price of Sun Pharma Advanced Research Company Ltd?

Answer Field: Sun Pharma Advanced Research Company Ltd share price is for NSE ₹ 130.34 & for BSE ₹ 129.85 as on Mar 19 2025 03:30 PM.

What is the Market Cap of Sun Pharma Advanced Research Company Ltd Share?

Answer Field: The market cap of Sun Pharma Advanced Research Company Ltd for NSE ₹ 42,29.81 & for BSE ₹ 42,13.91 as on Mar 19 2025 03:30 PM.

What is the P/E Ratio of Sun Pharma Advanced Research Company Ltd Share?

Answer Field: As on Mar 19 2025 03:30 PM the price-to-earnings (PE) ratio for Sun Pharma Advanced Research Company Ltd share is -10.44.

What is the PB ratio of Sun Pharma Advanced Research Company Ltd Share?

Answer Field: As on Mar 19 2025 03:30 PM, the price-to-book (PB) ratio for Sun Pharma Advanced Research Company Ltd share is 3.84.

How to Buy Sun Pharma Advanced Research Company Ltd Share?

Answer Field: You can trade in Sun Pharma Advanced Research Company Ltd shares with Bajaj Broking by opening a demat accountopens in a new tab.

How to Buy Sun Pharma Advanced Research Company Ltd Share on Bajaj Broking App?

Answer Field

To buy Sun Pharma Advanced Research Company Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sun Pharma Advanced Research Company Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Scan to download

Download from App Store

Download from Play Store

9 lakh+ Users

4.3+ App Rating

4 Languages

₹4300+ Cr MTF Book

Open Demat Account

Divine Hira Jewellers IPO is Open!

Open a Free Demat Account

Trade Now, Pay Later with up to 4x

Track Market Movers Instantly

Sun Pharma Adv.res.co.ltd Share Price

Sun Pharma Adv.res.co.ltd Share Price Update

Sun Pharma Adv.res.co.ltd Performance

Day Range

52 Week Range

Sun Pharma Adv.res.co.ltd Share Price

Open Price

125.60

Prev. Close

126.01

Volume (Shares)

2481753.00

Total traded value

3234.71

Upper Circuit

151.21

Lower Circuit

100.80

Sun Pharma Adv.res.co.ltd Fundamentals

Sun Pharma Adv.res.co.ltd Financials

Revenue

Net income

Technicals

Over 1 Month

-3.08

Over 3 Months

-42.19

Over 6 Months

-42.65

Over 1 Year

-65.28

Over 3 Years

-24.50

Over 5 Years

4.92

Sun Pharma Adv.res.co.ltd Future

Future: Price

Discount/Premium

Active Calls

Active Puts

Sun Pharma Adv.res.co.ltd Shareholding Pattern

Stock Holding

View Live Stock Screeners

Holding

Public

31.46

Promoter Holdings

65.67

FII

2.22

DII

0.63

Promoter Shares(Pledge Percentage)

0.0

Holding %

Pledges % of promoter shares %

MF Holding %

FII Holding %

Sun Pharma Adv.res.co.ltd

Learn More About Stocks

India proposes 12% safeguard duty on flat steel imports for 200 days

Premier Explosives Secures Rs 189 Million Defence Export Order

Delhi’s Power Demand to Cross Record 9,000 MW This Summer

G R Infraprojects Secures NHAI Project Worth Rs 42.63 Billion

About Sun Pharma Adv.res.co.ltd

Companies Owned by Sun Pharma Adv.res.co.ltd

Explore More Investment Options

Stocks

IPOs

MTF

US Stocks

Frequently Asked Questions

What is the Share Price of Sun Pharma Advanced Research Company Ltd?

What is the Market Cap of Sun Pharma Advanced Research Company Ltd?

What is the 52 Week High and Low of Sun Pharma Advanced Research Company Ltd?

How to Buy Sun Pharma Advanced Research Company Ltd share?